RESUMEN
The CONRAD Project is a Coordinated Network for Radiation Dosimetry funded by the European Commission 6th Framework Programme. The activities developed within CONRAD Work Package 5 ('Coordination of Research on Internal Dosimetry') have contributed to improve the harmonisation and reliability in the assessment of internal doses. The tasks carried out included a study of uncertainties and the refinement of the IDEAS Guidelines associated with the evaluation of doses after intakes of radionuclides. The implementation and quality assurance of new biokinetic models for dose assessment and the first attempt to develop a generic dosimetric model for DTPA therapy are important WP5 achievements. Applications of voxel phantoms and Monte Carlo simulations for the assessment of intakes from in vivo measurements were also considered. A Nuclear Emergency Monitoring Network (EUREMON) has been established for the interpretation of monitoring data after accidental or deliberate releases of radionuclides. Finally, WP5 group has worked on the update of the existing IDEAS bibliographic, internal contamination and case evaluation databases. A summary of CONRAD WP5 objectives and results is presented here.
Asunto(s)
Dosis de Radiación , Monitoreo de Radiación , Radiometría , Dosificación Radioterapéutica , Investigación , Simulación por Computador , Bases de Datos como Asunto , Humanos , Modelos Teóricos , Método de Montecarlo , Fantasmas de Imagen , Garantía de la Calidad de Atención de Salud , Radioisótopos/administración & dosificación , Radiometría/instrumentación , IncertidumbreRESUMEN
The EUropean RAdiation DOSimetry Group (EURADOS) initiated in 2005 the CONRAD Project, a Coordinated Network for Radiation Dosimetry funded by the European Commission (EC), within the 6th Framework Programme (FP). The main purpose of CONRAD is to generate a European Network in the field of Radiation Dosimetry and to promote both research activities and dissemination of knowledge. The objective of CONRAD Work Package 5 (WP5) is the coordination of research on assessment and evaluation of internal exposures. Nineteen institutes from 14 countries participate in this action. Some of the activities to be developed are continuations of former European projects supported by the EC in the 5th FP (OMINEX and IDEAS). Other tasks are linked with ICRP activities, and there are new actions never considered before. A collaboration is established with CONRAD Work Package 4, dealing with Computational Dosimetry, to organise an intercomparison on Monte Carlo modelling for in vivo measurements of (241)Am deposited in a knee phantom. Preliminary results associated with CONRAD WP5 tasks are presented here.
Asunto(s)
Academias e Institutos/organización & administración , Bioensayo/métodos , Unión Europea/organización & administración , Radiometría/tendencias , Investigación/organización & administración , Carga Corporal (Radioterapia) , HumanosRESUMEN
This paper describes the objectives, and reviews the progress, of the European project 'Treatment Initiatives After Radiological Accidents' (TIARA). TIARA forms part of the 'Preparatory Action for Security Research' (PASR) launched by the European Commission in 2004. The Preparatory Action is intended to reach preliminary conclusions on the needs for the security of EU citizens. It prepared a comprehensive Security Research Programme as part of the Commission's Seventh Framework Programme proposal, which was adopted in 2006 and launched in 2007. The principal purpose of TIARA is to constitute a European network that will participate in facilitating the management of a crisis in the event of the malevolent dispersal of radionuclides into the public environment.
Asunto(s)
Cuidados Críticos/métodos , Cuidados Críticos/organización & administración , Unión Europea/organización & administración , Traumatismos por Radiación/diagnóstico , Traumatismos por Radiación/terapia , Protectores contra Radiación/administración & dosificación , Liberación de Radiactividad Peligrosa/prevención & control , HumanosRESUMEN
The main activity of the RBDATA-EULEP project is the development of an electronic database of information on the biokinetics of radionuclides after intake by inhalation, ingestion or injection. It consists of linked tables of publications and experiments, with details and comments on the materials, procedures and results. By March 2004 it contained information on more than 1600 experiments from 600 publications. It will be extended and Internet access will also be provided.
Asunto(s)
Sistemas de Administración de Bases de Datos , Bases de Datos Factuales/normas , Modelos Biológicos , Protección Radiológica/normas , Radioisótopos/farmacocinética , Radiometría/métodos , Radiometría/normas , Carga Corporal (Radioterapia) , Europa (Continente) , Humanos , Almacenamiento y Recuperación de la Información/métodos , Almacenamiento y Recuperación de la Información/normas , Cooperación Internacional , Tasa de Depuración Metabólica , Control de Calidad , Dosis de Radiación , Protección Radiológica/métodos , Radioisótopos/análisis , Sociedades CientíficasRESUMEN
This paper provides guidance on the most appropriate monitoring procedures and intervals, the likely uncertainties in the assessment of intake and recommendations on appropriate investigation levels for repeated exposures to uranium trioxide, octoxide and dioxide of natural composition.
Asunto(s)
Contaminantes Radiactivos del Aire/farmacocinética , Heces/química , Riñón/metabolismo , Pulmón/metabolismo , Radiometría/métodos , Compuestos de Uranio/análisis , Compuestos de Uranio/farmacocinética , Absorción , Administración por Inhalación , Contaminantes Radiactivos del Aire/análisis , Animales , Humanos , Exposición por Inhalación/análisis , Tasa de Depuración Metabólica , Especificidad de Órganos , Dosis de Radiación , Tórax/metabolismo , Compuestos de Uranio/administración & dosificación , Compuestos de Uranio/orinaRESUMEN
Exposure limits for workers and the public are based on both chemical toxicity and radiation dose. As a consequence of the different procedures used in their calculation they are incompatible, and adherence to one limit may result in a serious breach of the other. This paper explores the background to these limits, the problems posed by their application and proposes how best to achieve compliance with both limits.
Asunto(s)
Contaminantes Radiactivos del Aire/farmacocinética , Exposición por Inhalación/análisis , Riñón/metabolismo , Exposición Profesional/análisis , Radiometría/métodos , Medición de Riesgo/métodos , Uranio/farmacocinética , Contaminantes Radiactivos del Aire/análisis , Concentración Máxima Admisible , Dosis de Radiación , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Uranio/análisisRESUMEN
The overall aim of the concerted action RBDATA-EULEP is to provide information to improve the assessments of intakes of radionuclides and of the resulting doses. This involves a review of the behaviour of radionuclides following intake, and the transfer of expertise on methodology by organising small training workshops. The main activity is the development of an electronic database, effectively an annotated bibliography, but the electronic format used facilitates extension, updating and information retrieval. It consists of linked tables of references and experiments, with details and comments on the materials, procedures and results. By June 2002 it contained information on 524 inhalation, 282 ingestion and 164 injection experiments from 391 references. It will be extended, and Internet access provided. Prospective users include groups developing standards for internal dosimetry, scientists conducting research on radionuclide biokinetics and health physicists assessing the consequences of accidental intakes.
Asunto(s)
Sistemas de Administración de Bases de Datos , Bases de Datos Factuales/normas , Modelos Biológicos , Protección Radiológica/normas , Radioisótopos/farmacocinética , Radiometría/métodos , Radiometría/normas , Carga Corporal (Radioterapia) , Europa (Continente) , Humanos , Almacenamiento y Recuperación de la Información/métodos , Almacenamiento y Recuperación de la Información/normas , Cooperación Internacional , Tasa de Depuración Metabólica , Control de Calidad , Dosis de Radiación , Protección Radiológica/métodos , Radioisótopos/análisis , Sociedades CientíficasRESUMEN
The introduction of new ICRP recommendations, especially the new Human Respiratory Tract Model (HRTM) in ICRP Publication 66 led us to focus on some specific parameters related to industrial uranium aerosols collected between 1990 and 1999 at French nuclear fuel fabrication facilities operated by COGEMA, FBFC, and the CEA. Among these parameters, the activity median aerodynamic diameter (AMAD), specific surface area (SSA), and parameters describing absorption to blood f(r), s(r) and s(s) defined in ICRP Publication 66 were identified as the most relevant influencing dose assessment. This study reviewed the data for 25 pure and impure uranium compounds. The average value of AMAD obtained was 5.7 microm (range 1.1-8.5 microm), which strongly supports the choice of 5 microm as the default value of AMAD for occupational exposures. The SSA varied between 0.4 and 18.3 m2 g(-1). For most materials, values of the absorption parameters f(r), s(r), and s(s) derived from the in vitro experiments were generally consistent with those derived from the in vivo experiments. Using average values for each pure compound allowed us to classify UO2 and U3O8 as Type S, mixed oxides, UF4, UO3 and ADU as Type M, and UO4 as Type F based on the ICRP Publication 71 criteria. Dose coefficients were also calculated for each pure compound, and average values for each type of pure compound were compared with those derived using default values. Finally, the lung retention kinetics and urinary excretion rates for inhaled U03 were compared using material-specific and default absorption parameters, in order to give a practical example of the application of this study.
Asunto(s)
Compuestos de Uranio/farmacocinética , Uranio/farmacocinética , Adsorción , Contaminantes Radiactivos del Aire/análisis , Animales , Humanos , Exposición Profesional , Monitoreo de Radiación , Protección Radiológica , Ratas , Factores de TiempoRESUMEN
An overview is given of the models recommended by the International Commission on Radiological Protection (ICRP) for assessing intakes and doses, and summarises biokinetic data obtained after the deposition of different chemical compounds of thorium in the rat lung. The results emphasise the importance of using material-specific data rather than default reference values for absorption into blood. The limitations of external monitoring of the chest or urine analysis are discussed, and comments made on alternative strategies for radiological protection of the worker.
Asunto(s)
Modelos Biológicos , Protección Radiológica/normas , Radiometría , Torio/farmacocinética , Administración por Inhalación , Animales , Humanos , Tasa de Depuración Metabólica , Exposición Profesional , Dosis de Radiación , Ratas , Distribución TisularRESUMEN
Comprehensive studies on the radiotoxicological risk of an intermediate compound UO4, which is not specified in ICRP Recommendations, were motivated by its increased use in the nuclear fuel cycle and the lack of information such as physico-chemical and biokinetic properties. The aim of this work was to give an experimental basis for assessing the appropriate limits on intake for workers exposed to UO4 and to provide guidance for the interpretation of personal monitoring data. Particle size measurement of the UO4 dust indicated a geometric diameter D of 0.5 microm, which corresponds to an activity median aerodynamic diameter (AMAD) of 1.1 microm. In vitro experiments conducted in culture medium showed that UO4 is a soluble compound with 66.2% dissolved in 1.9 d and 33.8% in 78 d. Results of dissolution obtained with macrophages showed a significant decrease of 50% at 1 d in terms of solubility. Biokinetic data in the rat obtained from two in vivo studies involving intratracheal instillation in rats indicated half-times in the lung of 0.5 d (96.6%) and 27 d (3.4%) for an initial lung deposit (ILD) of 195 microg, and 1.2 d (90.3%) and 38 d (9.7%) for an ILD of 7.6 microg. Absorption parameters to blood as defined in the ICRP Publication 66 human respiratory tract model were calculated with the specific software GIGAFIT and led to the rapid fraction fr (0.800 to 0.873), the rapid rate sr (0.525 to 0.928 d(-1)), and the slow rate ss (1.57 x 10(-2) to 2.42 x 10(-3) d(-1)). Effective dose coefficients by inhalation for this UO4 compound using the in vivo experimental results were calculated to be between 0.52 and 0.70 x 10(-6) Sv Bq(-1). Comparison of these values with effective dose coefficients defined in ICRP Publication 68 for workers showed that UO4 could be considered as a fast soluble compound of Type F.